{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:00:05Z","timestamp":1785549605046,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Unigen Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00403-020-02071-4","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T15:04:17Z","timestamp":1586185457000},"page":"725-730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation"],"prefix":"10.1007","volume":"312","author":[{"given":"Alexis B.","family":"Lyons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indermeet","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda F.","family":"Nahhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor L.","family":"Braunberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasneem F.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia L.","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan T.","family":"Nartker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat H.","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"issue":"4","key":"2071_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2310\/7750.2009.08077","volume":"13","author":"S Taylor","year":"2009","unstructured":"Taylor S et al (2009) Postinflammatory hyperpigmentation. J Cutan Med Surg 13(4):183\u2013191","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"2071_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jaad.2017.01.035","volume":"77","author":"N Silpa-Archa","year":"2017","unstructured":"Silpa-Archa N et al (2017) Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol 77(4):591\u2013605","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2071_CR3","first-page":"20","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis EC, Callender VD (2010) Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol 3(7):20\u201331","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"2071_CR4","first-page":"1","volume":"21","author":"B Sofen","year":"2016","unstructured":"Sofen B, Prado G, Emer J (2016) Melasma and post inflammatory hyperpigmentation: management update and expert opinion. Skin Therapy Lett 21(1):1\u20137","journal-title":"Skin Therapy Lett"},{"issue":"6 Suppl","key":"2071_CR5","first-page":"2","volume":"78","author":"L Baumann","year":"2006","unstructured":"Baumann L et al (2006) Natural considerations for skin of color. Cutis 78(6 Suppl):2\u201319","journal-title":"Cutis"},{"issue":"2","key":"2071_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0733-8635(18)30673-9","volume":"6","author":"PE Grimes","year":"1988","unstructured":"Grimes PE, Stockton T (1988) Pigmentary disorders in blacks. Dermatol Clin 6(2):271\u2013281","journal-title":"Dermatol Clin"},{"issue":"6","key":"2071_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ptr.972","volume":"16","author":"H Haraguchi","year":"2002","unstructured":"Haraguchi H, Inoue J, Tamura Y, Mizutani K (2002) Antioxidative components of Psoralea corylifolia (Leguminosae). Phytother Res 16(6):539\u2013544","journal-title":"Phytother Res"},{"issue":"11","key":"2071_CR8","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1128\/AAC.45.11.3009-3013.2001","volume":"45","author":"H Katsura","year":"2001","unstructured":"Katsura H et al (2001) In vitro antimicrobial activities of bakuchiol against oral microorganisms. Antimicrob Agents Chemother 45(11):3009\u20133013","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2071_CR9","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/bjd.14184","volume":"174","author":"P Isedeh","year":"2016","unstructured":"Isedeh P et al (2016) An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits. Br J Dermatol 174(4):862\u2013868","journal-title":"Br J Dermatol"},{"issue":"3","key":"2071_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/bjd.17746","volume":"181","author":"AB Lyons","year":"2019","unstructured":"Lyons AB, Kohli I, Lim HW, Hamzavi IH (2019) Insights on an in vivo model for postinflammatory hyperpigmentation. Br J Dermatol 181(3):598\u2013599","journal-title":"Br J Dermatol"},{"issue":"4","key":"2071_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaad.2017.01.036","volume":"77","author":"S Chaowattanapanit","year":"2017","unstructured":"Chaowattanapanit S et al (2017) Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J Am Acad Dermatol 77(4):607\u2013621","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"2071_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.jaad.2013.09.048","volume":"70","author":"WA Fisk","year":"2014","unstructured":"Fisk WA et al (2014) The use of botanically derived agents for hyperpigmentation: a systematic review. J Am Acad Dermatol 70(2):352\u2013365","journal-title":"J Am Acad Dermatol"},{"issue":"5\u20136","key":"2071_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0891-5849(99)00090-8","volume":"27","author":"L Packer","year":"1999","unstructured":"Packer L, Rimbach G, Virgili F (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med 27(5\u20136):704\u2013724","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"2071_CR14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.fct.2010.11.045","volume":"49","author":"LW Chang","year":"2011","unstructured":"Chang LW et al (2011) Antioxidant and antityrosinase activity of mulberry (Morus alba L.) twigs and root bark. Food Chem Toxicol 49(4):785\u2013790","journal-title":"Food Chem Toxicol"},{"issue":"13","key":"2071_CR15","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1021\/jf011703i","volume":"50","author":"P Charurin","year":"2002","unstructured":"Charurin P, Ames JM, del Castillo MD (2002) Antioxidant activity of coffee model systems. J Agric Food Chem 50(13):3751\u20133756","journal-title":"J Agric Food Chem"},{"issue":"6","key":"2071_CR16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jaad.2004.12.044","volume":"52","author":"S Hsu","year":"2005","unstructured":"Hsu S (2005) Green tea and the skin. J Am Acad Dermatol 52(6):1049\u20131059","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2071_CR17","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1211\/jpp.61.05.0016","volume":"61","author":"SJ Choo","year":"2009","unstructured":"Choo SJ et al (2009) Silymarin inhibits melanin synthesis in melanocyte cells. J Pharm Pharmacol 61(5):663\u2013667","journal-title":"J Pharm Pharmacol"},{"issue":"7","key":"2071_CR18","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1021\/jf9806762","volume":"47","author":"F Yamaguchi","year":"1999","unstructured":"Yamaguchi F et al (1999) Free radical scavenging activity of grape seed extract and antioxidants by electron spin resonance spectrometry in an H(2)O(2)\/NaOH\/DMSO system. J Agric Food Chem 47(7):2544\u20132548","journal-title":"J Agric Food Chem"},{"issue":"5","key":"2071_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1590\/S0365-05962010000500003","volume":"85","author":"A Costa","year":"2010","unstructured":"Costa A et al (2010) Association of emblica, licorice and belides as an alternative to hydroquinone in the clinical treatment of melasma. An Bras Dermatol 85(5):613\u2013620","journal-title":"An Bras Dermatol"},{"issue":"5","key":"2071_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/j.1365-2133.2007.07814.x","volume":"156","author":"A Khemis","year":"2007","unstructured":"Khemis A et al (2007) Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol 156(5):997\u20131004","journal-title":"Br J Dermatol"},{"key":"2071_CR21","first-page":"187","volume":"8","author":"K Polakova","year":"2015","unstructured":"Polakova K et al (2015) A dermocosmetic containing bakuchiol, Ginkgo biloba extract and mannitol improves the efficacy of adapalene in patients with acne vulgaris: result from a controlled randomized trial. Clin Cosmet Investig Dermatol 8:187\u2013191","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2 Suppl 1","key":"2071_CR22","first-page":"AB19","volume":"64","author":"A Shalita","year":"2011","unstructured":"Shalita A, Geen S, Lee WL, Yaping E (2011) A clinical study evaluating the dermatologic benefits of topical bakuchiol (UP256) cream on facial acne. J Am Acad Dermatol 64(2 Suppl 1):AB19","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-020-02071-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T23:28:13Z","timestamp":1617665293000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-020-02071-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2071"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02071-4","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"15 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Lyons is a sub-investigator for Incyte, Bayer, Unigen Inc., Lenicura, Estee Lauder, Miragen, Biofrontera. Dr. Kohli is a sub-investigator for Bayer, Estee Lauder, Unigen Inc., Ferndale laboratories, Allergan, Johnson & Johnson, Chromaderm, and Pfizer. Dr. Nahhas and Dr. Braunberger are sub-investigators for Bayer, Estee Lauder, Unigen Inc., and Ferndale laboratories. Dr. Mohammad, Dr. Nicholson, Nathan Narkter, and Krishna Modi have no relevant conflicts of interest to declare. Dr. Matsui was an employee of Estee Lauder. Dr. Lim is an investigator for Estee Lauder, Allergan, Ferndale laboratories, and Unigen Inc., and has served as a consultant to Pierre Fabre and ISDIN. Dr. Hamzavi is an investigator for Unigen Inc., Allergan, Clinuvel, Galderma, L\u2019Oreal, PCORI, Pfizer, Incyte Corporation, Bayer, Estee Lauder, Ferndale Healthcare Inc., Lenicura, General Electric, Janssen Biotech, and Johnson & Johnson and is the co-chair of the Global Vitiligo Foundation (unpaid), is on AbbVie advisory board (unpaid), and is a consultant for Incyte.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Henry Ford Hospital (IRB 9920).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Portions of this manuscript have been presented orally at the Society of Investigative Dermatology: Research in cutaneous surgery minisymposium on May 16, 2018 in Orlando, FL, at the Henry Ford Hospital Medical Education Research Forum on May 11, 2018 in Detroit, MI, at the American Academy of Dermatology Annual Meeting on March 3, 2019 in Washington, DC. Portions of this manuscript have been presented as a poster at the International Investigative Dermatology annual meeting on May 16\u201319, 2018 in Orlando, FL, the Annual Skin of Color Symposium on February 15, 2018 in San Diego, CA, and the World Congress of Dermatology on June 11\u201315 in Milan, Italy.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior presentation"}}]}}